Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/01jq-1y50

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Genome-Wide Association Study Links Autoimmune Addison’s Disease to Break of Central Tolerance
technical paper

Genome-Wide Association Study Links Autoimmune Addison’s Disease to Break of Central Tolerance

ENDO 2021

21 March 2021

Similar lecture

Biochemical Tumor Marker Status and Its Role in Treatment Response in Patients Who Received High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL): Results From a Pivotal Phase 2 Clinical Trial
technical paper

Biochemical Tumor Marker Status and Its Role in Treatment Response in Patients Who Received High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL): Results From a Pivotal Phase 2 Clinical Trial

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved